Treatment of Surfactant-Damaged Skin in Humans with Creams of Different pH Values.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 1, doi. 10.1159/000081068
- By:
- Publication type:
- Article
Works matching IS 00317012 AND DT 2005 AND VI 73 AND IP 1
Results: 7
1
2
Brain but Not Spinal NR2B Receptor Is Responsible for the Anti-Allodynic Effect of an NR2B Subunit-Selective Antagonist CP-101,606 in a Rat Chronic Constriction Injury Model.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 8, doi. 10.1159/000081069
- By:
- Publication type:
- Article
3
Modulation of Urokinase-Type Plasminogen Activator by Transforming Growth Factor β<sub>1</sub> in Acetaldehyde-Activated Hepatic Stellate Cells.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 23, doi. 10.1159/000081071
- By:
- Publication type:
- Article
4
Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, Dose- and Time-Dependently Protects against Focal Cerebral Ischemia in Mice.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 31, doi. 10.1159/000081072
- By:
- Publication type:
- Article
5
Therapeutic Potential of New Pt(II) and Ru(III) Triazole-Pyrimidine Complexes against Leishmania donovani.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 41, doi. 10.1159/000081073
- By:
- Publication type:
- Article
6
Reversal of Experimental Myoglobinuric Acute Renal Failure in Rats by Quercetin, a Bioflavonoid.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 49, doi. 10.1159/000081074
- By:
- Publication type:
- Article
7
Novel PPARγ Agonists GI 262570, GW 7845, GW 1929, and Pioglitazone Decrease Calcium Channel Function and Myogenic Tone in Rat Mesenteric Arteries.
- Published in:
- Pharmacology, 2005, v. 73, n. 1, p. 15, doi. 10.1159/000081070
- By:
- Publication type:
- Article